# Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery

> **NCT00858936** · PHASE2 · TERMINATED · sponsor: **Mallinckrodt** · enrollment: 6 (actual)

## Conditions studied

- Coronary Artery Bypass Surgery

## Interventions

- **DRUG:** IK-1001
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT00858936
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Study Terminated - Company decision
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00858936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00858936, "Reduction of Ischemia-Reperfusion Mediated Cardiac Injury in Subjects Undergoing Coronary Artery Bypass Graft Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00858936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*